Matinas Biopharma Holdings Inc (AMEX:MTNB) does about 1.26M shares in volume on a normal day but saw 7185653 shares change hands in Monday’s trading. The company now has a market cap of 80.42M USD. Its current market price is $0.37, marking an increase of 36.46% compared to the previous close of $0.27. The 52 week high reached by this stock is $0.89 whilst the lowest price level in 52 weeks is $0.11.
Matinas Biopharma Holdings Inc (MTNB) has a 20-day trading average at $0.2770 and the current price is -58.45% off the 52-week high compared with 235.27% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2442 and its 200-day simple moving average is $0.2447. If we look at the stock’s price movements over the week, volatility stands at 15.33%, which decreases to 14.63% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 69.96 to suggest the stock is neutral.
The consensus objective for the share price is $1.00, suggesting that the stock has a potential upside of 63.0% over the period.
Piper Sandler initiated its price target at $3.
Matinas Biopharma Holdings Inc (MTNB) stock is up 33.02% over the week and 32.02% over the past month. Its price is 71.05% year-to-date and -18.64% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of -$0.02 above consensus estimates by $0.01.
To reach the target analysts have set, the stock logically needs to grow 63.0 percent from here.
Outstanding shares total 217.26M with insiders holding 2.91% of the shares and institutional holders owning 12.05% of the company’s common stock. The company has a return on investment of -103.62% and return on equity of -82.11%. The beta has a value of 1.53. Price to book ratio is 4.17 and price to sales ratio is 73.11.
